Observational study for detailed blood sugar (BS) fluctuation in myotoic dystrophy by continuous glucose monitoring (CGM)
Not Applicable
- Conditions
- Myotonic dystrophy type 1 Amyotrophic neuromuscular disease
- Registration Number
- JPRN-UMIN000017800
- Lead Sponsor
- Dystrophia Myotonica: Clinical Treatment Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Medicated by insulin, DPP-4 inhibitor or GLP-1 agonist 2.Serious infection, perioperative or serious injury 3.Cardio-vascular event 4.Serious liver damage 5.Moderate or serious renal damage 6.Moderate or serious heart failure 7.Gestation or lactation period 8.Short bowel syndrome 9.Medicated by steroid, interferon, hormonal agent, atypical antipsychotic 10.Emaciation or skin disease with difficulty to be attached CGM 11.No informed consent with a form 12.Assessed as inadequate by a physician in charge
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Index by CGM (mean BS, SD of BS, M value, MAGE, BS area, proportion of hypoglycemia or hyperglycemia) and routine blood examination
- Secondary Outcome Measures
Name Time Method Results of oral glucose tolerance test